Gout

The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.

Rheumatology Network: Top Articles of 2022

December 31, 2022

Take a few minutes to review the most noteworthy studies published on Rheumatology Network in 2022.

Rheumatology Network's Month in Review: December 2022

December 24, 2022

Take 5 minutes to catch up on Rheumatology Network's top articles from December 2022.

Gout Year in Review: 2022

December 23, 2022

Theodore Fields, MD, FACP, discusses the most important gout studies in 2022, regulatory news, and the most pressing issues surrounding gout moving into 2023.

Metabolic Syndrome Identified Among Risk Factors for Early Onset Gout in Men

December 08, 2022

The incidence of gout, the most common type of inflammatory arthritis in men, has increased globally in recent decades.

Gout Linked to Higher Risk of Developing Osteoporosis

December 01, 2022

Results indicated that the incidence of osteoporosis increased up to 4 times in younger male patients with gout when compared with those without gout.

Monthly Gout Reviews Leads to Significant SUA Improvements

November 13, 2022

There was also a reduction in ultrasound features of gout at the knee identified, with improvement found in 63% of the tight control group and 14% of the conventional group.

Allopurinol Use Linked to Lower Risk of First-Ever Coronary Event

November 12, 2022

Exposure to more than 100 mg was linked to significantly lower odds ratios for first-ever ACS event for women.

Pegloticase Plus Methotrexate Co-Therapy did not Impact Renal Function in Gout

November 08, 2022

Abdul Abdellatif, MD, FASN, explains the results of the MIRROR RCT trial, in which the renal function of patients with gout receiving pegloticase plus methotrexate co-therapy was evaluated.

Early Gout Onset, Tophaceous Disease in Men Linked to Risk Alleles

November 01, 2022

"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”

Allopurinol Linked to Less Mortality in Patients with Gout and Cardiovascular Disease

October 28, 2022

Investigators concluded febuxostat should still be used cautiously for patients with gout and cardiovascular diseases due to inconclusive results.